Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy.
about
Androgen replacement therapy in the aging maleThe benefits and risks of testosterone replacement therapy: a reviewAndropause: Current conceptsThe role of routine serum testosterone testing: routine hormone analysis is not indicated as an initial screening test in the evaluation of erectile dysfunctionTestosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.Non-surgical management of erectile dysfunction.Erectile dysfunction in opioid users: lack of association with serum testosterone.Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency.The effects of testosterone deficiency on male sexual function.Hypogonadism and erectile dysfunction: the role for testosterone therapy.Hyperprolactinemia and sexual function in men: a short review.Andropause: endocrinology, erectile dysfunction, and prostate pathophysiology.Erectile dysfunction: symptom or disease?Testosterone therapy in erectile dysfunction.ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.Testosterone and erectile physiology.Testosterone treatment to mimic hormone physiology in androgen replacement therapy. A view on testosterone gel and other preparations available.Which patients with sexual dysfunction are suitable for testosterone replacement therapy?A relationship of sex hormone levels and erectile dysfunction: which tests should be done routinely?The relationship between hypogonadism and erectile dysfunction.ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.Androgens, health and sexuality in women and men.Androgens are fundamental in the maintenance of male sexual health.Prevalence of erectile dysfunction and its correlates: a population-based study in Morocco.Testosterone, endothelial health, and erectile function.Age as a differential characteristic of rapists, pedophiles, and sexual sadists.Viagra and broken hearts.Sildenafil citrate improves erectile function after castration in a rat model.The clinical studies of sildenafil for the ageing male.Patient satisfaction with testosterone supplementation for the treatment of erectile dysfunction.Is routine hormonal measurement necessary in initial evaluation of men with erectile dysfunction?Pituitary imaging findings in male patients with hypogonadotrophic hypogonadism.Validation of the German version of the 'Hypogonadism Related Symptom Scale' (HRS) in andrological patients with infertility, HIV infection and metabolic syndrome.Short-term use of sildenafil in the treatment of unconsumated marriages.ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.Association of serum testosterone levels and testicular volume in adult patients.The Effect of Transdermal Testosterone Administration on Lower Urinary Tract Symptoms and Erectile Dysfunction: A Prospective, Randomized, Placebo-Controlled Trial.
P2860
Q24551170-60ECFE5F-C01E-46FC-861D-B41E9F257C0AQ24658011-FB8587C6-E18F-45BC-8742-0B2BF0D70361Q27024886-6CCC6C87-2DDF-4326-8105-7291102BB453Q28200508-9178C67A-0494-494F-9551-6EBEBED024D7Q33276072-9D1FFF38-B898-49C1-8B5D-E35222D7CAD3Q33863945-5E4D1B33-7A5A-4365-AAA7-F1466313B193Q34183671-BBEF0471-15ED-4A3E-BCD8-A87595CCCA00Q34614190-01878CA8-A2AC-4632-97A9-F80615049EFDQ35082988-D4BF09F9-D5E5-470D-AF73-10844E9692D1Q35204827-A353C0D8-29A7-41A0-A234-5C6D79AE2281Q35561049-01088560-2A84-4D55-9995-F41DBB77D87DQ35648400-121AB4AA-5902-44CB-B3A5-BFE652FA650FQ35724843-878859F9-39F1-4634-B0B1-5E1F7BA33A6DQ36084048-BAC2D20A-CEB6-44AF-A7AA-96AE53CCDDBBQ36226980-1B3A1AEA-10A0-4FF3-9BB8-B6A044E2342CQ36687900-8670E734-C9EF-44CA-A870-2E49DD6D91E9Q36897412-608C2C21-09EA-4EC1-AF91-AB9B7E7B271BQ37030456-9DD9C6BA-C6CC-46BB-996E-CE31BA6D9DEAQ37065731-473A7A2F-3EEE-4D75-970E-ABC1ABE37BDCQ37096549-60101531-F94C-4A99-9D4B-309C88E14DC5Q37299250-F3E0BC8A-5E78-491D-9386-204C7A23166FQ37310024-30481CC2-8018-4762-AF14-03E1386E61C7Q37813672-15E53C0D-F50C-415B-9FEE-16ED11057517Q37885800-14CA347B-5519-4852-AA3F-F0B6F135268DQ38905991-E028026C-AEFF-483F-8E55-36766CAD5848Q40549792-B09D4E8E-219C-4B7A-BACF-4F69280DB62CQ40642116-DC57796C-D912-4173-8C29-5BC7F912EFFCQ42351902-D627DCBF-4486-4D69-BDFF-81F6862594E8Q43485171-17E4E9C3-0763-4C4A-BEC7-B65BBB881243Q43899123-F31110E4-200D-463C-8E69-E075B9C5E467Q44212094-7AFBC20A-F911-42DA-8849-6BF22CA68251Q44995210-34516611-63CB-4196-9C8F-1F39C86BCD20Q45220536-037D0BC9-7664-43DD-9106-BBB26EAE626CQ45808458-E9802FCA-D28E-492F-943F-51B4006161F6Q46148449-6766EF49-E72F-4EF6-B70C-211703DA3E8FQ46397195-3C01BE0F-392D-4D6A-A178-3BC642E38DACQ48128177-DD702FC1-8260-434C-9805-08F1BB0480FEQ49788378-049728AD-4A78-48E0-B9EF-14E81F2B5DD2
P2860
Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Endocrine screening in 1,022 m ...... e and cost-effective strategy.
@en
type
label
Endocrine screening in 1,022 m ...... e and cost-effective strategy.
@en
prefLabel
Endocrine screening in 1,022 m ...... e and cost-effective strategy.
@en
P1476
Endocrine screening in 1,022 m ...... e and cost-effective strategy.
@en
P2093
P304
P356
10.1016/S0022-5347(01)64123-5
P407
P577
1997-11-01T00:00:00Z